The Food and Drug Administration uses accelerated wear testing on heart valves to determine the lifespan of this device. To begin understanding the effect of accelerated wear on porcine, mitral, bioprosthetic heart valves, the effective orifice area is determined at varying points in the cardiac cycle. A comparison to published in vivo and computational data on physiological valve motion helps to understand the similarities and differences between both conditions.